Hatem Alharazin

Hatem Alharazin is a Clinical Trial Solutions Analyst at One2Treat since September 2023, contributing to the mission of integrating key patient-relevant outcomes for comprehensive assessment of treatment effects. Previously, Hatem served as a Statistical Analyst at IDDI - Biostatistics & eClinical Experts from March 2023 to March 2024, and worked as a Data Scientist at Wellbeing.ai from March 2022 to March 2023. Hatem also has research experience with the National Bank of Belgium, focusing on mathematical and statistical methods for temporal disaggregation and benchmarking in national accounts from September 2019 to August 2020. Hatem holds a Master's degree in Statistics from KU Leuven (2017 - 2020) and a Bachelor's degree in Statistics from Azhar University - Gaza (2007 - 2011).